Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Diabetes Research and Clinical Practice|December 27, 2017
Effects of evolving lipid-lowering drugs on carbohydrate metabolismV Tsimihodimos, M ElisafCurrent Pharmaceutical Design|February 10, 2009
Pleiotropic effects of fenofibrateV Tsimihodimos, E Liberopoulos, M ElisafInternational Journal of Clinical Practice|June 4, 2009
Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implicationsV Tsimihodimos, V Kakaidi, M ElisafDiabetes & Metabolic Syndrome|June 18, 2018
SGLT2 inhibitors and the kidney: Effects and mechanismsV Tsimihodimos, T D Filippatos, M S ElisafDiabetes & Metabolism|December 6, 2016
Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysisF Barkas, M Elisaf, V Tsimihodimos, et al.Current Vascular Pharmacology|October 18, 2016
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption InhibitionV Tsimihodimos, T D Filippatos, S Filippas-Ntekouan, et al.Diabetes & Metabolic Syndrome|August 23, 2017
SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanismsT D Filippatos, V Tsimihodimos, G Liamis, et al.Thyroid : Official Journal of the American Thyroid Association|May 13, 1999
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicV Tsimihodimos, E Bairaktari, C Tzallas, et al.Lipids|February 18, 2011
High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemiaA P Agouridis, V Tsimihodimos, T D Filippatos, et al.Clinical Biochemistry|September 10, 1999
Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patientsE Bairaktari, M Elisaf, A Katsaraki, et al.Pageof 2